(Q53577999)

15 May 2018

title

One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients. (English)

1 reference

15 May 2018

main subject

anti-retroviral agent

0 references

author

Wan Beom Park

1

1 reference

15 May 2018

author name string

Choe PG

2

1 reference

15 May 2018

Kim SH

3

1 reference

15 May 2018

Jo JH

4

1 reference

15 May 2018

Bang JH

5

1 reference

15 May 2018

Kim HB

6

1 reference

15 May 2018

Kim NJ

7

1 reference

15 May 2018

Oh M

8

1 reference

15 May 2018

Choe KW

9

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 March 2007

1 reference

15 May 2018

Journal of Internal Medicine

published in

1 reference

15 May 2018

volume

261

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

268-275

1 reference

15 May 2018

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Compliance/adherence and care management in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Highly active antiretroviral therapy outcomes in a primary care clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Prevalence and predictive value of intermittent viremia with combination hiv therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01762.X

10.1111/J.1365-2796.2006.01762.X

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018